News
Pharmaceutical Technology on MSN8h
FDA approves Akeso’s monoclonal antibody for nasopharyngeal carcinomaThe antibody is to treat adult recurrent or metastatic non-keratinising nasopharyngeal carcinoma (NPC) in conjunction with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback